No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Malignant neoplasm of thyroid gland based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thyroid gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 15625 | 11702 | 3769 |
Only index persons | 12721 | 9842 | 2879 |
Unadjusted period prevalence (%) | |||
Whole population | 0.28 | 0.34 | 0.11 |
Only index persons | 0.30 | 0.36 | 0.11 |
Median age at first event (years) | |||
Whole population | 52.49 | 51.32 | 55.98 |
Only index persons | 50.21 | 49.13 | 53.92 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2311 | 1705 | 606 |
Unadjusted period prevalence (%) | 0.57 | 0.67 | 0.30 |
Median age at first event (years) | 50.93 | 48.38 | 58.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint C3_THYROID_GLAND_EXALLC and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_THYROID_GLAND_EXALLC | 1.632 [1.45, 1.84] | < 0.001 |
Birth year | 0.998 [0.99, 1.01] | 0.649 |
During the follow-up period (1.1.1998 — 31.12.2019), 921 out of 6639 females with C3_THYROID_GLAND_EXALLC died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_THYROID_GLAND_EXALLC | 2.137 [1.83, 2.49] | < 0.001 |
Birth year | 0.994 [0.98, 1.0] | 0.173 |
During the follow-up period (1.1.1998 — 31.12.2019), 583 out of 2206 males with C3_THYROID_GLAND_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_THYROID_GLAND_EXALLC.N-year risk | Females | Males |
---|---|---|
1 | 0.16% | 0.347% |
5 | 1.072% | 2.409% |
10 | 2.421% | 6.52% |
15 | 4.844% | 13.15% |
20 | 8.801% | 22.141% |
Relationships between endpoints
↥Index endpoint: C3_THYROID_GLAND_EXALLC – Malignant neoplasm of thyroid gland
GWS hits: 9